×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Bio-Techne Corp. (TECH) NASDAQ

$74.53 (0.01) (-0.01%)

Market Cap: $11.75B

As of 06/20/24 04:00 PM EDT. Market closed.

(TECH)

Bio-Techne Corp. (TECH)
NASDAQ

$74.53
(0.01) (-0.01%)

Market Cap: $11.75B

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Charles Kummeth
Full Time Employees
1,595
CEO Compensation (Base)
$957,000
CEO Compensation (Total)
$11.01M
URL
Address
614 McKinley Pl NE, Minnesota, Minneapolis, 55413-2610.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Charles Kummeth
Full Time Employees
1,595
CEO Compensation (Base)
$957,000
CEO Compensation (Total)
$11.01M
Address
614 McKinley Pl NE, Minnesota, Minneapolis, 55413-2610.
PRICE CHART FOR BIO-TECHNE CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$73.95
Previous Close
$74.54
Days Range
$73.43 - $75.25
52 week range
$51.42 - $89.19
Volume
784,181
Avg. Volume (30 days)
848,842
Market Cap
$11.75B
Dividend Yield
0.43%
P/E
57.87
Shares Outstanding
157,584,637
Open
$73.95
Previous Close
$74.54
Days Range
$73.43 - $75.25
52 week range
$51.42 - $89.19
Volume
784,181
Avg. Volume (30 days)
848,842
Market Cap
$11.75B
Dividend Yield
0.43%
P/E
57.87
Shares Outstanding
157,584,637
FINANCIAL STATEMENTS FOR BIO-TECHNE CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIO-TECHNE CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
HIGGINS JOHN LDirectorMay 14, 2024 Option Exercise$22.954,00091,80040,608May 16, 2024, 04:17 PM
HIGGINS JOHN LDirectorMay 14, 2024 Sale$83.844,000335,37736,608May 16, 2024, 04:17 PM
Bohnen ShaneSVP - General CounselApr 03, 2024 Option Exercise$67.8774750,6991,647Apr 05, 2024, 04:53 PM
Nusse RoelandDirectorMar 07, 2024 Sale$76.9810,400800,62743,097Mar 11, 2024, 04:04 PM
Geist WilliamPRESIDENT, PROTEIN SCIENCESFeb 01, 2024 Option Exercise$68.541,11176,1487,759Feb 05, 2024, 06:36 PM
Hippel JamesCFODec 19, 2023 Option Exercise$77.4232,9662,552,22871,884Dec 21, 2023, 04:06 PM
Hippel JamesCFODec 19, 2023 Option Exercise$31.2647,2891,478,254104,850Dec 21, 2023, 04:06 PM
Nusse RoelandDirectorAug 30, 2023 Option Exercise$22.4032,000716,80060,811Sep 01, 2023, 04:06 PM
Nusse RoelandDirectorAug 30, 2023 Sale$80.328,939717,95951,872Sep 01, 2023, 04:06 PM
Kelderman KimPres. Diagnostics & GenomAug 24, 2023 Option Exercise$47.602,10099,96021,225Aug 28, 2023, 04:19 PM
Kummeth Charles R.Chief Executive OfficerAug 15, 2023 Option Exercise$84.618,675733,9921,278,269Aug 17, 2023, 04:14 PM
Kummeth Charles R.Chief Executive OfficerAug 05, 2023 Option Exercise$82.1731,9622,626,3171,278,320Aug 08, 2023, 05:31 PM
Hippel JamesCFOAug 05, 2023 Option Exercise$82.176,335520,54757,561Aug 08, 2023, 05:29 PM
Kelderman KimPres. Diagnostics & GenomAug 05, 2023 Option Exercise$82.174,139340,10219,125Aug 08, 2023, 05:28 PM
Kummeth Charles R.Chief Executive OfficerJul 21, 2023 Sale$88.3680,0007,069,0241,258,766Jul 25, 2023, 05:27 PM
Kummeth Charles R.Chief Executive OfficerJun 30, 2023 Option Exercise$81.63390,72731,895,0441,338,766Jul 05, 2023, 06:38 PM
Kummeth Charles R.Chief Executive OfficerJun 30, 2023 Option Exercise$26.65616,67616,434,4151,729,493Jul 05, 2023, 06:38 PM
Kummeth Charles R.Chief Executive OfficerJun 07, 2023 Sale$83.0032226,7261,112,817Jun 09, 2023, 04:07 PM
HIGGINS JOHN LDirectorApr 28, 2023 Option Exercise$79.884,377349,63534,983May 02, 2023, 04:49 PM
HIGGINS JOHN LDirectorApr 28, 2023 Option Exercise$21.8516,000349,60039,360May 02, 2023, 04:49 PM
Kummeth Charles R.Chief Executive OfficerJan 04, 2023 Option Exercise$84.39255,83721,590,0841,113,139Jan 06, 2023, 04:37 PM
Kummeth Charles R.Chief Executive OfficerJan 04, 2023 Option Exercise$26.65407,36410,856,2501,368,976Jan 06, 2023, 04:37 PM
Furlow Brenda S.SVP - GENERAL COUNSELDec 08, 2022 Option Exercise$31.267,450232,90633,542Dec 09, 2022, 04:48 PM
Furlow Brenda S.SVP - GENERAL COUNSELDec 07, 2022 Option Exercise$31.2680025,01026,892Dec 09, 2022, 04:48 PM
Furlow Brenda S.SVP - GENERAL COUNSELDec 08, 2022 Sale$82.127,450611,81026,092Dec 09, 2022, 04:48 PM
Furlow Brenda S.SVP - GENERAL COUNSELDec 07, 2022 Sale$82.0180065,60526,092Dec 09, 2022, 04:48 PM
Kelderman KimPres. Diagnostics & GenomAug 23, 2022 Option Exercise$150.7866399,9673,801Aug 25, 2022, 05:38 PM
HIGGINS JOHN LDirectorAug 10, 2022 Option Exercise$66.903,400227,4608,006Aug 12, 2022, 04:02 PM
HIGGINS JOHN LDirectorAug 11, 2022 Sale$385.39512197,3225,510Aug 12, 2022, 04:02 PM
HIGGINS JOHN LDirectorAug 10, 2022 Sale$377.111,992751,1947,106Aug 12, 2022, 04:02 PM
Furlow Brenda S.SVP - General CounselAug 08, 2022 Option Exercise$177.3256399,8316,523Aug 10, 2022, 06:08 PM
Kelderman KimPres. Diagnostics & GenomAug 07, 2022 Option Exercise$382.971,214464,9263,138Aug 09, 2022, 07:00 PM
Furlow Brenda S.SVP - General CounselAug 07, 2022 Option Exercise$382.97969371,0985,960Aug 09, 2022, 06:59 PM
Kummeth Charles R.Chief Executive OfficerAug 07, 2022 Option Exercise$382.9711,5574,425,984240,403Aug 09, 2022, 06:58 PM
Hippel JamesChief Financial OfficerAug 07, 2022 Option Exercise$382.971,938742,19612,755Aug 09, 2022, 06:57 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJul 28, 2022 Option Exercise$380.7627,70710,549,718235,042Aug 01, 2022, 06:11 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJul 28, 2022 Option Exercise$108.4945,3464,919,587262,749Aug 01, 2022, 06:11 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJul 06, 2022 Option Exercise$362.7830,93511,222,599217,403Jul 08, 2022, 05:18 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJul 06, 2022 Option Exercise$108.4950,0005,424,500248,338Jul 08, 2022, 05:18 PM
HIGGINS JOHN LDirectorJun 08, 2022 Option Exercise$66.9060040,1405,206Jun 09, 2022, 05:07 PM
HIGGINS JOHN LDirectorJun 07, 2022 Option Exercise$66.901,00066,9005,606Jun 09, 2022, 05:07 PM
HIGGINS JOHN LDirectorJun 07, 2022 Sale$364.311,000364,3104,606Jun 09, 2022, 05:07 PM
HIGGINS JOHN LDirectorJun 08, 2022 Sale$366.09600219,6544,606Jun 09, 2022, 05:07 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJun 07, 2022 Option Exercise$108.495,104553,733203,442Jun 09, 2022, 05:05 PM
Kummeth Charles R.CHIEF EXECUTIVE OFFICERJun 07, 2022 Sale$365.005,1041,862,960198,338Jun 09, 2022, 05:05 PM
BAUMGARTNER ROBERT VDirectorMay 10, 2022 Buy$352.55300105,76510,106May 11, 2022, 04:52 PM
Kelderman KimPres. Diagnostics & GenomFeb 08, 2022 Option Exercise$150.781,989299,9011,989Feb 10, 2022, 04:31 PM
Kummeth Charles R.Chief Executive OfficerJan 28, 2022 Option Exercise$115.081,737199,896198,338Feb 01, 2022, 04:35 PM
Kelderman KimPres. Diagnostics & GenomNov 19, 2021 Option Exercise$150.7850075,390500Nov 23, 2021, 08:02 PM
Kelderman KimPres. Diagnostics & GenomNov 19, 2021 Sale$505.38500252,689400Nov 23, 2021, 08:02 PM
Eansor Norman DavidPresident-Protein SciencesNov 16, 2021 Option Exercise$125.0579999,9152,117Nov 16, 2021, 04:51 PM
Eansor Norman DavidPresident-Protein SciencesNov 12, 2021 Option Exercise$125.0527,1593,396,23328,477Nov 16, 2021, 04:51 PM
Eansor Norman DavidPresident-Protein SciencesNov 12, 2021 Sale$504.0027,15913,688,19627,777Nov 16, 2021, 04:51 PM
Hippel JamesChief Financial OfficerNov 02, 2021 Option Exercise$125.0520025,01010,955Nov 03, 2021, 05:29 PM
Hippel JamesChief Financial OfficerNov 01, 2021 Option Exercise$125.058,8221,103,19119,577Nov 03, 2021, 05:29 PM
Hippel JamesChief Financial OfficerNov 02, 2021 Sale$525.10200105,02010,755Nov 03, 2021, 05:29 PM
Hippel JamesChief Financial OfficerNov 01, 2021 Sale$526.528,8224,644,96816,011Nov 03, 2021, 05:29 PM
Hippel JamesChief Financial OfficerOct 29, 2021 Option Exercise$125.0566282,78311,417Nov 01, 2021, 04:36 PM
Hippel JamesChief Financial OfficerOct 28, 2021 Sale$525.1810052,51810,755Nov 01, 2021, 04:36 PM
Hippel JamesChief Financial OfficerOct 29, 2021 Sale$525.23662347,70410,755Nov 01, 2021, 04:36 PM
Kelderman KimPres. Diagnostics & GenomSep 22, 2021 Sale$529.04822434,8710Sep 24, 2021, 04:30 PM
STEER RANDOLPH CDirectorSep 07, 2021 Option Exercise$89.588,000716,68013,112Sep 09, 2021, 04:26 PM
STEER RANDOLPH CDirectorSep 07, 2021 Sale$509.988,0004,079,82410,212Sep 09, 2021, 04:26 PM
Kummeth Charles R.Chief Executive OfficerSep 02, 2021 Option Exercise$510.7842,00521,455,314196,601Sep 07, 2021, 05:00 PM
Kummeth Charles R.Chief Executive OfficerSep 02, 2021 Option Exercise$108.4973,4927,973,147238,606Sep 07, 2021, 05:00 PM
Hippel JamesChief Financial OfficerSep 02, 2021 Option Exercise$106.5910,0001,065,90020,855Sep 07, 2021, 04:59 PM
Hippel JamesChief Financial OfficerSep 02, 2021 Sale$507.2210,0005,072,16410,862Sep 07, 2021, 04:59 PM
Furlow Brenda S.SVP - General CounselSep 02, 2021 Option Exercise$125.056,871859,21914,491Sep 07, 2021, 04:58 PM
Furlow Brenda S.SVP - General CounselSep 02, 2021 Sale$509.946,8713,503,7679,196Sep 07, 2021, 04:58 PM
Eansor Norman DavidPresident-Protein SciencesAug 31, 2021 Sale$503.071,538773,7281,318Sep 02, 2021, 04:49 PM
Furlow Brenda S.SVP - General CounselAug 31, 2021 Option Exercise$125.055,000625,25012,620Sep 02, 2021, 04:48 PM
Furlow Brenda S.SVP - General CounselAug 31, 2021 Sale$505.665,0002,528,31212,297Sep 02, 2021, 04:48 PM
Nusse RoelandDirectorAug 23, 2021 Option Exercise$70.354,000281,40010,765Aug 25, 2021, 05:13 PM
Nusse RoelandDirectorAug 23, 2021 Sale$481.524,0001,926,0646,765Aug 25, 2021, 05:13 PM
BAUMGARTNER ROBERT VDirectorAug 23, 2021 Option Exercise$87.394,000349,56013,612Aug 25, 2021, 04:42 PM
BAUMGARTNER ROBERT VDirectorAug 23, 2021 Sale$485.554,0001,942,18413,313Aug 25, 2021, 04:42 PM
Furlow Brenda S.SVP - General CounselAug 19, 2021 Option Exercise$109.994,337477,03011,158Aug 23, 2021, 04:15 PM
Furlow Brenda S.SVP - General CounselAug 19, 2021 Sale$473.953,5381,676,85010,058Aug 23, 2021, 04:15 PM
Kummeth Charles R.Chief Executive OfficerAug 11, 2021 Option Exercise$108.4992199,919165,114Aug 13, 2021, 04:03 PM
Kummeth Charles R.Chief Executive OfficerAug 06, 2021 Option Exercise$481.8212,4756,010,705164,193Aug 10, 2021, 06:22 PM
Hippel JamesChief Financial OfficerAug 08, 2021 Option Exercise$481.821,665802,23010,855Aug 10, 2021, 06:21 PM
Hippel JamesChief Financial OfficerAug 09, 2021 Option Exercise$106.5910,0001,065,90020,855Aug 10, 2021, 06:21 PM
Hippel JamesChief Financial OfficerAug 09, 2021 Sale$478.9010,0004,788,99415,655Aug 10, 2021, 06:21 PM
Kelderman KimPres. Diagnostics & GenomAug 08, 2021 Option Exercise$481.82869418,702822Aug 10, 2021, 06:21 PM
Furlow Brenda S.SVP - General CounselAug 08, 2021 Option Exercise$481.82677326,1926,821Aug 10, 2021, 06:20 PM
Eansor Norman DavidPresident-Protein SciencesAug 08, 2021 Option Exercise$481.82999481,3382,856Aug 10, 2021, 06:19 PM
Hippel JamesChief Financial OfficerJul 12, 2021 Option Exercise$106.5910,0001,065,90019,137Jul 14, 2021, 04:57 PM
Hippel JamesChief Financial OfficerJul 12, 2021 Sale$456.6710,0004,566,66318,537Jul 14, 2021, 04:57 PM
Kelderman KimPres. Diagnostics & GenomMay 01, 2021 Option Exercise$427.49856365,9311,656May 04, 2021, 04:54 PM
Kummeth Charles R.Chief Executive OfficerFeb 16, 2021 Option Exercise$411.0017,4287,162,908158,841Feb 18, 2021, 12:00 AM
Kummeth Charles R.Chief Executive OfficerFeb 16, 2021 Option Exercise$94.3530,0002,830,500176,269Feb 18, 2021, 12:00 AM
Hippel JamesChief Financial OfficerFeb 12, 2021 Option Exercise$106.5910,0001,065,90019,137Feb 17, 2021, 04:46 PM
Hippel JamesChief Financial OfficerFeb 12, 2021 Sale$400.3910,0004,003,9099,737Feb 17, 2021, 04:46 PM
Furlow Brenda S.SVP - General CounselFeb 12, 2021 Option Exercise$106.5910,0001,065,90016,124Feb 17, 2021, 04:42 PM
Furlow Brenda S.SVP - General CounselFeb 12, 2021 Sale$398.6310,0003,986,3489,450Feb 17, 2021, 04:42 PM
Nusse RoelandDirectorFeb 08, 2021 Option Exercise$67.486,000404,85012,765Feb 10, 2021, 04:26 PM
Nusse RoelandDirectorFeb 08, 2021 Sale$385.086,0002,310,4806,765Feb 10, 2021, 04:26 PM
Kelderman KimPres. Diagnostics & GenomFeb 05, 2021 Sale$388.45823319,694845Feb 09, 2021, 06:31 PM
Eansor Norman DavidPresident-Protein SciencesFeb 05, 2021 Option Exercise$106.5932,9333,510,32834,251Feb 09, 2021, 05:24 PM
Eansor Norman DavidPresident-Protein SciencesFeb 05, 2021 Sale$380.6832,93312,537,02428,251Feb 09, 2021, 05:24 PM
Kummeth Charles R.Chief Executive OfficerJan 15, 2021 Sale$344.0020,0006,880,000146,269Jan 20, 2021, 04:42 PM
Hippel JamesChief Financial OfficerJan 11, 2021 Option Exercise$106.5910,0001,065,90019,137Jan 13, 2021, 05:18 PM
Hippel JamesChief Financial OfficerJan 11, 2021 Sale$333.6310,0003,336,32318,737Jan 13, 2021, 05:18 PM
Kummeth Charles R.Chief Executive OfficerDec 07, 2020 Sale$308.005,0001,540,000166,269Dec 09, 2020, 04:28 PM
Furlow Brenda S.SVP - General CounselNov 30, 2020 Option Exercise$106.5911,7951,257,22916,981Dec 02, 2020, 06:01 PM
Furlow Brenda S.SVP - General CounselNov 30, 2020 Sale$301.9410,8573,278,12813,614Dec 02, 2020, 06:01 PM
BAUMGARTNER ROBERT VDirectorNov 18, 2020 Option Exercise$66.905,000334,50014,612Nov 20, 2020, 04:29 PM
BAUMGARTNER ROBERT VDirectorNov 18, 2020 Sale$303.335,0001,516,6759,612Nov 20, 2020, 04:29 PM
Seth AlpnaDirectorNov 09, 2020 Option Exercise$145.755,023732,1187,162Nov 19, 2020, 12:27 PM
Seth AlpnaDirectorNov 09, 2020 Sale$306.625,0231,540,1675,804Nov 19, 2020, 12:27 PM
Hippel JamesChief Financial OfficerNov 11, 2020 Option Exercise$106.597,391787,80716,528Nov 12, 2020, 06:59 PM
Hippel JamesChief Financial OfficerNov 09, 2020 Option Exercise$106.593,600383,72412,737Nov 12, 2020, 06:59 PM
Hippel JamesChief Financial OfficerNov 09, 2020 Sale$309.793,6001,115,25211,637Nov 12, 2020, 06:59 PM
Hippel JamesChief Financial OfficerNov 11, 2020 Sale$307.057,3912,269,42610,237Nov 12, 2020, 06:59 PM
Kummeth Charles R.Chief Executive OfficerNov 06, 2020 Option Exercise$302.4715,3754,650,476171,269Nov 10, 2020, 06:04 PM
Kummeth Charles R.Chief Executive OfficerNov 06, 2020 Option Exercise$86.2525,1572,169,791186,644Nov 10, 2020, 06:04 PM
STEER RANDOLPH CDirectorNov 06, 2020 Option Exercise$68.6310,000686,25015,112Nov 10, 2020, 06:00 PM
STEER RANDOLPH CDirectorNov 06, 2020 Sale$301.9910,0003,019,94813,389Nov 10, 2020, 06:00 PM
HIGGINS JOHN LDirectorNov 06, 2020 Option Exercise$70.355,000351,7509,412Nov 10, 2020, 04:53 PM
HIGGINS JOHN LDirectorNov 06, 2020 Sale$300.355,0001,501,7467,962Nov 10, 2020, 04:53 PM
Hippel JamesChief Financial OfficerNov 05, 2020 Option Exercise$108.498,809955,68817,946Nov 06, 2020, 04:47 PM
Hippel JamesChief Financial OfficerNov 04, 2020 Option Exercise$108.497,100770,27916,237Nov 06, 2020, 04:47 PM
Hippel JamesChief Financial OfficerNov 05, 2020 Sale$286.128,8092,520,45417,548Nov 06, 2020, 04:47 PM
Hippel JamesChief Financial OfficerNov 04, 2020 Sale$274.007,1001,945,42614,682Nov 06, 2020, 04:47 PM
Furlow Brenda S.SVP - General CounselAug 09, 2020 Option Exercise$265.76849225,6305,186Aug 11, 2020, 06:22 PM
Eansor Norman DavidPresident-Protein SciencesAug 09, 2020 Option Exercise$265.76856227,4911,318Aug 11, 2020, 06:21 PM
Hippel JamesChief Financial OfficerAug 09, 2020 Option Exercise$265.762,184580,4209,137Aug 11, 2020, 06:21 PM
Kummeth Charles R.Chief Executive OfficerAug 09, 2020 Option Exercise$265.7612,2873,265,393161,487Aug 11, 2020, 06:20 PM
Furlow Brenda S.SVP - General CounselJul 09, 2020 Option Exercise$108.499,079984,98113,390Jul 13, 2020, 04:02 PM
Furlow Brenda S.SVP - General CounselJul 09, 2020 Sale$275.769,0792,503,65412,950Jul 13, 2020, 04:02 PM
Hippel JamesChief Financial OfficerJul 07, 2020 Option Exercise$108.492,577279,57911,884Jul 08, 2020, 05:47 PM
Hippel JamesChief Financial OfficerJul 06, 2020 Option Exercise$108.4921,5022,332,75230,809Jul 08, 2020, 05:47 PM
Hippel JamesChief Financial OfficerJul 07, 2020 Sale$271.432,577699,48211,470Jul 08, 2020, 05:47 PM
Hippel JamesChief Financial OfficerJul 06, 2020 Sale$271.6121,5025,840,14821,238Jul 08, 2020, 05:47 PM
WIENS HAROLD JDirectorMay 29, 2020 Option Exercise$101.193,985403,2428,828Jun 02, 2020, 05:13 PM
WIENS HAROLD JDirectorMay 29, 2020 Sale$260.003,9851,036,1004,843Jun 02, 2020, 05:13 PM
Furlow Brenda S.SVP - General CounselMay 28, 2020 Option Exercise$105.517,595801,35810,306Jun 01, 2020, 05:58 PM
Furlow Brenda S.SVP - General CounselMay 28, 2020 Sale$260.145,9951,559,5348,111Jun 01, 2020, 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 29, 2020 Option Exercise$108.497,909858,0477,909Jun 01, 2020, 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 28, 2020 Option Exercise$108.493,448374,0743,448Jun 01, 2020, 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 28, 2020 Sale$260.193,448897,1350Jun 01, 2020, 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 29, 2020 Sale$262.007,9092,072,1406,209Jun 01, 2020, 05:58 PM
Kummeth Charles R.Chief Executive OfficerMay 26, 2020 Option Exercise$266.4013,0183,467,995138,130May 28, 2020, 05:41 PM
Kummeth Charles R.Chief Executive OfficerMay 26, 2020 Option Exercise$86.2521,1591,824,964151,148May 28, 2020, 05:41 PM
Eansor Norman DavidPresident-Protein SciencesMay 22, 2020 Option Exercise$104.0412,6001,310,93712,600May 26, 2020, 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 21, 2020 Option Exercise$94.3511,0371,041,34111,037May 26, 2020, 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 22, 2020 Sale$267.9312,6003,375,9264,924May 26, 2020, 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 21, 2020 Sale$267.4911,0372,952,316900May 26, 2020, 05:13 PM
BAUMGARTNER ROBERT VDirectorMay 21, 2020 Option Exercise$70.355,000351,75014,221May 26, 2020, 05:13 PM
BAUMGARTNER ROBERT VDirectorMay 21, 2020 Sale$266.425,0001,332,11812,921May 26, 2020, 05:13 PM
WIENS HAROLD JDirectorMay 06, 2020 Option Exercise$87.344,260372,0689,481May 08, 2020, 04:17 PM
WIENS HAROLD JDirectorMay 06, 2020 Sale$250.004,2601,065,0005,221May 08, 2020, 04:17 PM
Kelderman KimPres. Diagnostics & GenomMay 01, 2020 Option Exercise$227.54821186,8101,668May 05, 2020, 04:28 PM
WIENS HAROLD JDirectorApr 30, 2020 Option Exercise$91.784,000367,1209,221May 04, 2020, 04:35 PM
WIENS HAROLD JDirectorApr 30, 2020 Sale$225.004,000900,0005,221May 04, 2020, 04:35 PM
Eansor Norman DavidPresident-Protein SciencesMar 04, 2020 Sale$198.681,387275,5690Mar 06, 2020, 04:08 PM
HIGGINS JOHN LDirectorFeb 12, 2020 Option Exercise$61.465,000307,3009,021Feb 14, 2020, 04:13 PM
HIGGINS JOHN LDirectorFeb 12, 2020 Sale$205.235,0001,026,1354,021Feb 14, 2020, 04:13 PM
Kummeth Charles R.Chief Executive OfficerJan 06, 2020 Option Exercise$67.4610,276693,219140,265Jan 08, 2020, 04:34 PM
Kummeth Charles R.Chief Executive OfficerJan 06, 2020 Sale$217.2810,2762,232,769129,989Jan 08, 2020, 04:34 PM
Kummeth Charles R.Chief Executive OfficerJan 02, 2020 Option Exercise$67.4619,8431,338,609149,832Jan 06, 2020, 12:00 AM
Kummeth Charles R.Chief Executive OfficerJan 03, 2020 Option Exercise$67.467,999539,613137,988Jan 06, 2020, 12:00 AM
Kummeth Charles R.Chief Executive OfficerJan 03, 2020 Sale$217.567,9991,740,240131,730Jan 06, 2020, 12:00 AM
Kummeth Charles R.Chief Executive OfficerJan 02, 2020 Sale$218.5919,8434,337,541143,383Jan 06, 2020, 12:00 AM
Kummeth Charles R.Chief Executive OfficerDec 24, 2019 Option Exercise$67.4647131,774130,460Dec 27, 2019, 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 23, 2019 Option Exercise$67.4665944,456130,648Dec 27, 2019, 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 24, 2019 Sale$222.18471104,648129,989Dec 27, 2019, 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 23, 2019 Sale$222.08659146,351129,989Dec 27, 2019, 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 20, 2019 Option Exercise$67.465,767389,042135,756Dec 23, 2019, 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 20, 2019 Sale$222.065,7671,280,632129,989Dec 23, 2019, 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 20, 2019 Option Exercise$67.465,767389,042135,756Dec 23, 2019, 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 20, 2019 Sale$222.065,7671,280,632129,989Dec 23, 2019, 04:31 PM
Furlow Brenda S.SVP - General CounselDec 12, 2019 Option Exercise$94.358,000754,80010,711Dec 17, 2019, 04:32 PM
Furlow Brenda S.SVP - General CounselDec 12, 2019 Sale$215.608,0001,724,77310,285Dec 17, 2019, 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 10, 2019 Option Exercise$67.4670347,424136,459Dec 12, 2019, 04:35 PM
Kummeth Charles R.Chief Executive OfficerDec 10, 2019 Sale$222.01703156,073135,756Dec 12, 2019, 04:35 PM
WIENS HAROLD JDirectorDec 04, 2019 Option Exercise$87.832,000175,6607,221Dec 06, 2019, 04:50 PM
WIENS HAROLD JDirectorDec 04, 2019 Sale$217.852,000435,6936,736Dec 06, 2019, 04:50 PM
Kummeth Charles R.Chief Executive OfficerNov 27, 2019 Option Exercise$67.4611,772794,139147,628Dec 02, 2019, 04:22 PM
Kummeth Charles R.Chief Executive OfficerNov 29, 2019 Sale$222.6210022,262135,756Dec 02, 2019, 04:22 PM
Kummeth Charles R.Chief Executive OfficerNov 27, 2019 Sale$222.1211,7722,614,820135,856Dec 02, 2019, 04:22 PM
Nusse RoelandDirectorNov 25, 2019 Option Exercise$60.7915,000911,90020,721Nov 29, 2019, 11:35 AM
Nusse RoelandDirectorNov 25, 2019 Sale$219.338,3471,830,73112,374Nov 29, 2019, 11:35 AM
Hippel JamesChief Financial OfficerNov 22, 2019 Option Exercise$94.3523,6512,231,47232,958Nov 25, 2019, 04:25 PM
Hippel JamesChief Financial OfficerNov 21, 2019 Option Exercise$94.3511,3491,070,77820,656Nov 25, 2019, 04:25 PM
Hippel JamesChief Financial OfficerNov 22, 2019 Sale$215.5923,6515,098,89910,907Nov 25, 2019, 04:25 PM
Hippel JamesChief Financial OfficerNov 21, 2019 Sale$215.3611,3492,444,1329,307Nov 25, 2019, 04:25 PM
Kummeth Charles R.Chief Executive OfficerSep 09, 2019 Buy$185.0010018,500100Sep 11, 2019, 04:42 PM
Kummeth Charles R.Chief Executive OfficerSep 09, 2019 Buy$185.0010018,500100Sep 11, 2019, 04:42 PM
Eansor Norman DavidSVP - Novus BiologicalsAug 19, 2019 Option Exercise$197.57900177,8131,387Aug 21, 2019, 04:34 PM
Hippel JamesChief Financial OfficerAug 19, 2019 Option Exercise$197.572,424478,9106,883Aug 21, 2019, 04:33 PM
Furlow Brenda S.SVP - General CounselAug 19, 2019 Option Exercise$197.57745147,1903,203Aug 21, 2019, 04:32 PM
Kummeth Charles R.Chief Executive OfficerAug 13, 2019 Option Exercise$67.467,410499,879110,877Aug 15, 2019, 04:45 PM
BAUMGARTNER ROBERT VDirectorAug 07, 2019 Buy$191.0650095,5308,726Aug 09, 2019, 04:12 PM
Kummeth Charles R.Chief Executive OfficerJul 10, 2019 Option Exercise$67.4616,9691,144,729109,145Jul 12, 2019, 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 10, 2019 Sale$213.1216,9693,616,427102,579Jul 12, 2019, 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 09, 2019 Option Exercise$67.4615,0371,014,396107,213Jul 10, 2019, 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08, 2019 Option Exercise$67.4617,9941,213,875110,170Jul 10, 2019, 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 09, 2019 Sale$212.4315,0373,194,34092,176Jul 10, 2019, 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08, 2019 Sale$212.7517,9943,828,18892,176Jul 10, 2019, 04:46 PM
Eansor Norman DavidSVP - Novus BiologicalsJun 12, 2019 Sale$215.003,117670,1550Jun 14, 2019, 04:13 PM
HIGGINS JOHN LDirectorJun 04, 2019 Option Exercise$63.035,000315,1508,526Jun 06, 2019, 04:30 PM
HIGGINS JOHN LDirectorJun 04, 2019 Sale$203.675,0001,018,3453,526Jun 06, 2019, 04:30 PM
Furlow Brenda S.SVP - General CounselMay 24, 2019 Sale$200.005,4001,080,0002,189May 29, 2019, 04:29 PM
Kelderman KimPresident, Diagnostics & GenomMay 01, 2019 Option Exercise$202.13844170,598823May 02, 2019, 04:18 PM
Kelderman KimPresident, Diagnostics & GenomMay 01, 2019 Option Exercise$202.131,667336,9511,667May 02, 2019, 04:18 PM
Hippel JamesChief Financial OfficerMay 01, 2019 Option Exercise$86.2535,0003,018,75039,382May 02, 2019, 04:14 PM
Hippel JamesChief Financial OfficerMay 01, 2019 Sale$203.0835,0007,107,6954,382May 02, 2019, 04:14 PM
Kummeth Charles R.Chief Executive OfficerAug 18, 2018 Option Exercise$180.501,338241,50992,176Aug 31, 2018, 04:39 PM
BAUMGARTNER ROBERT VDirectorAug 24, 2018 Option Exercise$61.465,000307,30012,712Aug 28, 2018, 05:30 PM
BAUMGARTNER ROBERT VDirectorAug 24, 2018 Sale$188.475,000942,3357,712Aug 28, 2018, 05:30 PM
HIGGINS JOHN LDirectorAug 23, 2018 Option Exercise$61.0810,000610,80013,012Aug 27, 2018, 04:12 PM
HIGGINS JOHN LDirectorAug 23, 2018 Sale$187.9210,0001,879,1703,012Aug 27, 2018, 04:12 PM
Dinarello Charles ADirectorAug 08, 2018 Option Exercise$63.035,000315,15013,212Aug 10, 2018, 04:18 PM
Dinarello Charles ADirectorAug 08, 2018 Sale$176.935,000884,6758,212Aug 10, 2018, 04:18 PM
Kummeth Charles R.Chief Executive OfficerAug 07, 2018 Option Exercise$180.148,0531,450,66783,987Aug 09, 2018, 07:22 PM
Eansor Norman DavidSVP - Novus BiologicalsAug 07, 2018 Option Exercise$180.1434862,6893,117Aug 09, 2018, 06:29 PM
Furlow Brenda S.SVP - General CounselAug 07, 2018 Option Exercise$180.1443878,9012,189Aug 09, 2018, 06:26 PM
Hippel JamesChief Financial OfficerAug 07, 2018 Option Exercise$180.141,094197,0734,382Aug 09, 2018, 06:19 PM
Kummeth Charles R.Chief Executive OfficerJun 07, 2018 Sale$160.008,0001,280,00076,472Jun 08, 2018, 04:21 PM
Eansor Norman DavidSVP - Novus BiologicalsMay 04, 2018 Sale$145.191,136164,9312,266May 11, 2018, 04:16 PM
Dinarello Charles ADirectorFeb 13, 2018 Option Exercise$65.475,000327,35013,212Feb 15, 2018, 04:02 PM
Dinarello Charles ADirectorFeb 13, 2018 Sale$136.065,000680,30310,717Feb 15, 2018, 04:02 PM
BAUMGARTNER ROBERT VDirectorNov 01, 2017 Option Exercise$63.035,000315,15012,712Nov 03, 2017, 04:41 PM
BAUMGARTNER ROBERT VDirectorNov 01, 2017 Sale$130.185,000650,9057,712Nov 03, 2017, 04:41 PM
LUCAS ROGER CDirectorOct 10, 2017 Sale$121.9610012,1961,870Oct 12, 2017, 04:24 PM
LUCAS ROGER CDirectorSep 08, 2017 Sale$120.9410012,0941,970Sep 12, 2017, 05:02 PM
HOLBROOK KAREN ADirectorSep 06, 2017 Sale$121.731,059128,909914Sep 08, 2017, 04:44 PM
LUCAS ROGER CDirectorAug 10, 2017 Sale$114.3010011,4302,070Aug 14, 2017, 04:24 PM
LUCAS ROGER CDirectorJul 10, 2017 Sale$116.8610011,6862,170Jul 12, 2017, 04:34 PM
Gould Kevin SSVP Clinical ControlsJul 09, 2017 Option Exercise$117.6831236,7161,355Jul 11, 2017, 05:30 PM
Eansor Norman DavidSVP - Novus BiologicalsJul 01, 2017 Option Exercise$117.5053462,7453,402Jul 05, 2017, 05:46 PM
Furlow Brenda S.Jul 01, 2017 Option Exercise$117.5027832,6651,668Jul 05, 2017, 12:00 AM
LUCAS ROGER CDirectorJun 09, 2017 Sale$113.6210011,3622,270Jun 13, 2017, 04:56 PM
LUCAS ROGER CDirectorMay 22, 2017 Sale$110.011,059116,5052,370Jun 01, 2017, 04:51 PM
Dinarello Charles ADirectorMay 26, 2017 Option Exercise$66.595,000332,95012,473May 31, 2017, 04:58 PM
Dinarello Charles ADirectorMay 31, 2017 Sale$111.375,000556,8607,473May 31, 2017, 04:58 PM
HOLBROOK KAREN ADirectorMay 25, 2017 Option Exercise$66.595,000332,9506,973May 30, 2017, 04:34 PM
HOLBROOK KAREN ADirectorMay 25, 2017 Sale$111.155,000555,7751,973May 30, 2017, 04:34 PM
LUCAS ROGER CDirectorMay 10, 2017 Sale$110.5910011,0593,429May 12, 2017, 04:16 PM
LUCAS ROGER CDirectorApr 10, 2017 Sale$101.1510010,1153,551Apr 12, 2017, 04:52 PM
Hippel JamesChief Financial OfficerMar 31, 2017 Option Exercise$101.6580081,3203,079Apr 04, 2017, 06:20 PM
LUCAS ROGER CDirectorMar 10, 2017 Sale$107.7710010,7773,650Mar 14, 2017, 04:43 PM
LUCAS ROGER CDirectorFeb 10, 2017 Sale$102.6010010,2603,729Feb 14, 2017, 05:03 PM
LUCAS ROGER CDirectorJan 10, 2017 Sale$103.5710010,3573,829Jan 12, 2017, 05:02 PM
LUCAS ROGER CDirectorDec 09, 2016 Sale$108.9310010,8933,929Dec 13, 2016, 04:31 PM
HOLBROOK KAREN ADirectorNov 29, 2016 Sale$106.731,000106,7331,973Dec 01, 2016, 04:30 PM
LUCAS ROGER CDirectorNov 16, 2016 Sale$105.7510010,5754,029Nov 18, 2016, 04:33 PM
LUCAS ROGER CDirectorOct 19, 2016 Sale$104.7110010,4713,215Oct 31, 2016, 05:10 PM
LUCAS ROGER CDirectorSep 21, 2016 Sale$108.9110010,8913,315Sep 23, 2016, 04:40 PM
Gould Kevin SSVP Clinical ControlsSep 08, 2016 Sale$110.5052457,9041,667Sep 12, 2016, 05:27 PM
HIGGINS JOHN LDirectorSep 08, 2016 Sale$109.831,700186,7161,359Sep 12, 2016, 05:27 PM
BAUMGARTNER ROBERT VDirectorSep 01, 2016 Option Exercise$65.903,854253,9649,913Sep 06, 2016, 04:36 PM
BAUMGARTNER ROBERT VDirectorSep 02, 2016 Option Exercise$65.472,613171,0738,672Sep 06, 2016, 04:36 PM
BAUMGARTNER ROBERT VDirectorSep 01, 2016 Sale$107.183,854413,0526,059Sep 06, 2016, 04:36 PM
BAUMGARTNER ROBERT VDirectorSep 02, 2016 Sale$107.152,613279,9866,059Sep 06, 2016, 04:36 PM
BAUMGARTNER ROBERT VDirectorAug 24, 2016 Option Exercise$66.593,533235,2629,592Aug 26, 2016, 05:38 PM
BAUMGARTNER ROBERT VDirectorAug 24, 2016 Sale$107.103,533378,3776,059Aug 26, 2016, 05:38 PM
LUCAS ROGER CDirectorAug 17, 2016 Sale$113.7010011,3703,415Aug 19, 2016, 04:58 PM
LUCAS ROGER CDirectorJul 20, 2016 Sale$111.0310011,1033,615Jul 21, 2016, 11:50 AM
Gould Kevin SSVP Clinical ControlsJul 09, 2016 Option Exercise$115.1730935,5882,191Jul 12, 2016, 05:33 PM
Furlow Brenda S.SVP - General CounselJul 01, 2016 Option Exercise$112.2427731,0901,946Jul 06, 2016, 05:11 PM
Eansor Norman DavidSVP - Novus BiologicalsJul 01, 2016 Option Exercise$112.2453359,8243,936Jul 06, 2016, 05:11 PM
LUCAS ROGER CDirectorJun 15, 2016 Sale$112.1510011,2153,715Jun 16, 2016, 12:27 PM
LUCAS ROGER CDirectorMay 18, 2016 Sale$102.5310010,2533,815May 19, 2016, 03:47 PM
Dinarello Charles ADirectorMay 09, 2016 Sale$101.915,000509,5506,559May 10, 2016, 05:43 PM
Dinarello Charles ADirectorMay 05, 2016 Option Exercise$56.175,000280,85011,559May 09, 2016, 02:14 PM
LUCAS ROGER CDirectorMay 06, 2016 Sale$100.2450050,1203,915May 09, 2016, 02:14 PM
LUCAS ROGER CDirectorApr 20, 2016 Sale$92.401009,2404,315Apr 22, 2016, 04:06 PM
Hippel JamesMar 31, 2016 Option Exercise$94.5255652,5535,544Apr 04, 2016, 02:57 PM
LUCAS ROGER CDirectorMar 16, 2016 Sale$92.901009,2904,415Mar 18, 2016, 01:03 PM
LUCAS ROGER CDirectorFeb 05, 2016 Option Exercise$70.355,000351,7509,515Feb 08, 2016, 05:48 PM
LUCAS ROGER CDirectorFeb 05, 2016 Sale$83.685,000418,4004,515Feb 08, 2016, 05:48 PM
LUCAS ROGER CDirectorAug 17, 2015 Option Exercise$66.905,000334,5008,456Aug 19, 2015, 04:35 PM
LUCAS ROGER CDirectorAug 17, 2015 Sale$106.025,000530,1103,456Aug 19, 2015, 04:35 PM
LUCAS ROGER CDirectorAug 13, 2015 Option Exercise$61.465,000307,3008,456Aug 17, 2015, 04:32 PM
LUCAS ROGER CDirectorAug 13, 2015 Sale$106.015,000530,0353,456Aug 17, 2015, 04:32 PM
Furlow Brenda S.SVP - General CounselAug 07, 2015 Option Exercise$97.545,540540,3722,223Aug 11, 2015, 04:41 PM
Eansor Norman DavidSVP BiotechJul 02, 2015 Option Exercise$96.5453151,2631,136Jul 06, 2015, 10:03 AM
STEER RANDOLPH CDirectorJun 08, 2015 Sale$99.391,00099,3861,000Jun 09, 2015, 10:33 AM
VERONNEAU MARCELSVP - Clinical ControlsJun 08, 2015 Option Exercise$98.7530930,51434,604Jun 09, 2015, 10:18 AM
VERONNEAU MARCELSVP - Clinical ControlsJun 08, 2015 Option Exercise$79.4138530,57334,989Jun 09, 2015, 10:18 AM
Hippel JamesChief Financial OfficerMar 31, 2015 Option Exercise$100.2956656,7641,100Apr 02, 2015, 04:32 PM
OCONNELL HOWARD VDirectorFeb 19, 2015 Option Exercise$56.175,000280,85075,000Feb 20, 2015, 01:38 PM
OCONNELL HOWARD VDirectorFeb 19, 2015 Sale$95.785,000478,88270,000Feb 20, 2015, 01:38 PM
Dinarello Charles ADirectorFeb 05, 2015 Option Exercise$54.911,50082,3655,500Feb 06, 2015, 03:40 PM
HOLBROOK KAREN ADirectorDec 10, 2014 Sale$92.401,00092,4001,000Dec 12, 2014, 10:42 AM
Dinarello Charles ADirectorDec 08, 2014 Sale$90.443,000271,3204,000Dec 10, 2014, 04:57 PM
REAGAN KEVIN JSenior VP - BiotechDec 09, 2014 Option Exercise$70.962,591183,8572,591Dec 09, 2014, 04:14 PM
REAGAN KEVIN JSenior VP - BiotechDec 05, 2014 Option Exercise$70.961,00070,9601,000Dec 09, 2014, 04:14 PM
REAGAN KEVIN JSenior VP - BiotechDec 09, 2014 Sale$89.322,591231,4320Dec 09, 2014, 04:14 PM
REAGAN KEVIN JSenior VP - BiotechDec 05, 2014 Sale$89.411,00089,4120Dec 09, 2014, 04:14 PM
Dinarello Charles ADirectorSep 09, 2014 Option Exercise$54.915,000274,5506,000Sep 10, 2014, 04:29 PM
HOLBROOK KAREN ADirectorAug 14, 2014 Option Exercise$57.065,000285,3006,000Aug 15, 2014, 05:19 PM
HOLBROOK KAREN ADirectorAug 14, 2014 Sale$95.545,000477,7001,000Aug 15, 2014, 05:19 PM
VERONNEAU MARCELVP Clinical ControlsJun 02, 2014 Option Exercise$87.3433128,91034,403Jun 03, 2014, 11:38 AM
VERONNEAU MARCELVP Clinical ControlsJun 02, 2014 Option Exercise$56.8351028,98334,913Jun 03, 2014, 11:38 AM
OCONNELL HOWARD VDirectorMay 06, 2014 Option Exercise$54.6893451,07170,934May 08, 2014, 10:17 AM
OCONNELL HOWARD VDirectorMay 07, 2014 Option Exercise$54.684,066222,32974,066May 08, 2014, 10:17 AM
OCONNELL HOWARD VDirectorMay 06, 2014 Sale$91.0093484,99470,000May 08, 2014, 10:17 AM
OCONNELL HOWARD VDirectorMay 07, 2014 Sale$91.004,066370,00670,000May 08, 2014, 10:17 AM
HOLBROOK KAREN ADirectorMar 04, 2014 Option Exercise$57.065,000285,3006,000Mar 06, 2014, 11:11 AM
HOLBROOK KAREN ADirectorMar 04, 2014 Sale$89.835,000449,1501,000Mar 06, 2014, 11:11 AM
STEER RANDOLPH CDirectorFeb 27, 2014 Option Exercise$61.465,000307,3006,000Feb 28, 2014, 12:34 PM
STEER RANDOLPH CDirectorFeb 27, 2014 Sale$88.785,000443,9001,000Feb 28, 2014, 12:34 PM
LUCAS ROGER CDirectorFeb 19, 2014 Option Exercise$65.0315,000975,45017,456Feb 21, 2014, 04:15 PM
LUCAS ROGER CDirectorFeb 19, 2014 Sale$90.0315,0001,350,5072,456Feb 21, 2014, 04:15 PM
STEER RANDOLPH CDirectorNov 13, 2013 Option Exercise$65.0315,000975,45016,000Nov 15, 2013, 09:37 AM
STEER RANDOLPH CDirectorNov 13, 2013 Sale$86.2015,0001,293,0001,000Nov 15, 2013, 09:37 AM
BAUMGARTNER ROBERT VDirectorNov 08, 2013 Option Exercise$55.4210,000554,25014,000Nov 12, 2013, 09:58 AM
BAUMGARTNER ROBERT VDirectorNov 08, 2013 Sale$87.0010,000870,0004,000Nov 12, 2013, 09:58 AM
LUCAS ROGER CDirectorNov 04, 2013 Option Exercise$55.4210,000554,25012,456Nov 05, 2013, 05:46 PM
LUCAS ROGER CDirectorNov 04, 2013 Sale$87.6410,000876,4002,456Nov 05, 2013, 05:46 PM
VERONNEAU MARCELVP Clinical ControlsJul 01, 2013 Option Exercise$69.6940228,01534,167Jul 03, 2013, 12:06 PM
VERONNEAU MARCELVP Clinical ControlsJul 01, 2013 Option Exercise$49.4356728,02734,734Jul 03, 2013, 12:06 PM
OCONNELL HOWARD VDirectorMay 06, 2013 Buy$65.002,361153,46570,000May 07, 2013, 01:03 PM
MELSEN GREGORY JCEODec 18, 2012 Option Exercise$49.431,01250,0231,438Dec 19, 2012, 10:38 AM
OCONNELL HOWARD VDirectorOct 27, 2012 Option Exercise$71.6520,0001,433,00067,639Nov 28, 2012, 11:22 AM
OCONNELL HOWARD VDirectorOct 26, 2012 Option Exercise$37.105,000185,50095,639Nov 28, 2012, 11:22 AM
OCONNELL HOWARD VDirectorOct 26, 2012 Sale$71.818,000574,48087,639Nov 28, 2012, 11:22 AM
VERONNEAU MARCELVP Hematology OperationsAug 14, 2012 Option Exercise$51.6047524,51035,044Aug 16, 2012, 04:04 PM
VERONNEAU MARCELVP Hematology OperationsAug 14, 2012 Sale$67.5747532,09634,569Aug 16, 2012, 04:04 PM
MELSEN GREGORY JVP Finance and CFOJul 31, 2012 Option Exercise$51.6042621,982426Aug 01, 2012, 09:54 AM
OLAND THOMAS ECEO, PresidentNov 30, 2011 Option Exercise$67.492,000134,9801,177,420Dec 06, 2011, 12:57 PM
OCONNELL HOWARD VDirectorDec 05, 2011 Option Exercise$66.5235023,28290,639Dec 05, 2011, 05:26 PM
OLAND THOMAS ECEO, PresidentNov 30, 2011 Option Exercise$67.492,000134,9801,177,420Nov 30, 2011, 09:53 PM
OCONNELL HOWARD VDirectorNov 29, 2011 Option Exercise$65.0230,0001,950,60090,989Nov 29, 2011, 04:31 PM
BAUMGARTNER ROBERT VDirectorNov 25, 2011 Buy$62.611,00062,6103,000Nov 28, 2011, 10:27 AM
VERONNEAU MARCELVP Hematology OperationsMay 26, 2011 Option Exercise$40.4750520,43735,074May 31, 2011, 11:23 AM
VERONNEAU MARCELVP Hematology OperationsMay 26, 2011 Sale$81.2050541,00434,569May 31, 2011, 11:23 AM
BAUMGARTNER ROBERT VDirectorMay 09, 2011 Option Exercise$36.605,680207,8727,680May 09, 2011, 04:23 PM
BAUMGARTNER ROBERT VDirectorMay 06, 2011 Option Exercise$32.901,88562,0173,885May 09, 2011, 04:23 PM
BAUMGARTNER ROBERT VDirectorMay 06, 2011 Sale$78.681,885148,3122,000May 09, 2011, 04:23 PM
BAUMGARTNER ROBERT VDirectorMay 09, 2011 Sale$78.505,680445,8802,000May 09, 2011, 04:23 PM
BAUMGARTNER ROBERT VDirectorMay 04, 2011 Option Exercise$32.902,43580,1124,435May 05, 2011, 12:15 PM
BAUMGARTNER ROBERT VDirectorMay 04, 2011 Sale$78.842,435191,9742,000May 05, 2011, 12:15 PM
OCONNELL HOWARD VDirectorMay 04, 2011 Option Exercise$78.561,640128,838120,989May 05, 2011, 11:53 AM
OCONNELL HOWARD VDirectorMay 04, 2011 Option Exercise$31.7810,000317,750137,629May 05, 2011, 11:37 AM
OCONNELL HOWARD VDirectorMay 04, 2011 Sale$79.1915,0001,187,807122,629May 05, 2011, 11:37 AM
OCONNELL HOWARD VDirectorDec 08, 2010 Option Exercise$29.103,00087,300130,629Dec 09, 2010, 04:58 PM
OCONNELL HOWARD VDirectorDec 08, 2010 Sale$61.303,000183,900127,629Dec 09, 2010, 04:58 PM
OLAND THOMAS ECEO, PresidentNov 09, 2010 Option Exercise$60.222,000120,4401,179,420Nov 10, 2010, 09:12 AM
OCONNELL HOWARD VDirectorNov 03, 2010 Option Exercise$52.6610,000526,565137,629Nov 04, 2010, 11:35 AM
OCONNELL HOWARD VDirectorNov 03, 2010 Sale$61.0110,000610,100127,629Nov 04, 2010, 11:35 AM
VERONNEAU MARCELVP Hematology OperationsNov 02, 2010 Option Exercise$61.314,520277,12127,080Nov 04, 2010, 11:08 AM
VERONNEAU MARCELVP Hematology OperationsNov 03, 2010 Option Exercise$37.017,511277,99042,080Nov 04, 2010, 11:08 AM
VERONNEAU MARCELVP Hematology OperationsNov 02, 2010 Option Exercise$37.017,489277,17534,569Nov 04, 2010, 11:08 AM
VERONNEAU MARCELVP Hematology OperationsNov 03, 2010 Sale$61.087,511458,77234,569Nov 04, 2010, 11:08 AM
LUCAS ROGER CDirectorAug 20, 2010 Option Exercise$52.6610,000526,56511,456Aug 24, 2010, 09:34 AM
LUCAS ROGER CDirectorAug 20, 2010 Sale$60.0110,000600,1501,456Aug 24, 2010, 09:34 AM
VERONNEAU MARCELVP Hematology OperationsAug 04, 2010 Option Exercise$61.4436922,67130,930Aug 06, 2010, 10:57 AM
VERONNEAU MARCELVP Hematology OperationsAug 04, 2010 Option Exercise$33.8567022,67931,600Aug 06, 2010, 10:57 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
HIGGINS JOHN LDirector05/14/202491,800
HIGGINS JOHN LDirector05/14/2024335,377
Bohnen ShaneSVP - General Counsel04/03/202450,699
Nusse RoelandDirector03/07/2024800,627
Geist WilliamPRESIDENT, PROTEIN SCIENCES02/01/202476,148
Hippel JamesCFO12/19/20232,552,228
Hippel JamesCFO12/19/20231,478,254
Nusse RoelandDirector08/30/2023716,800
Nusse RoelandDirector08/30/2023717,959
Kelderman KimPres. Diagnostics & Genom08/24/202399,960
Kummeth Charles R.Chief Executive Officer08/15/2023733,992
Kummeth Charles R.Chief Executive Officer08/05/20232,626,317
Hippel JamesCFO08/05/2023520,547
Kelderman KimPres. Diagnostics & Genom08/05/2023340,102
Kummeth Charles R.Chief Executive Officer07/21/20237,069,024
Kummeth Charles R.Chief Executive Officer06/30/202331,895,044
Kummeth Charles R.Chief Executive Officer06/30/202316,434,415
Kummeth Charles R.Chief Executive Officer06/07/202326,726
HIGGINS JOHN LDirector04/28/2023349,635
HIGGINS JOHN LDirector04/28/2023349,600
Kummeth Charles R.Chief Executive Officer01/04/202321,590,084
Kummeth Charles R.Chief Executive Officer01/04/202310,856,250
Furlow Brenda S.SVP - GENERAL COUNSEL12/08/2022232,906
Furlow Brenda S.SVP - GENERAL COUNSEL12/07/202225,010
Furlow Brenda S.SVP - GENERAL COUNSEL12/08/2022611,810
Furlow Brenda S.SVP - GENERAL COUNSEL12/07/202265,605
Kelderman KimPres. Diagnostics & Genom08/23/202299,967
HIGGINS JOHN LDirector08/10/2022227,460
HIGGINS JOHN LDirector08/11/2022197,322
HIGGINS JOHN LDirector08/10/2022751,194
Furlow Brenda S.SVP - General Counsel08/08/202299,831
Kelderman KimPres. Diagnostics & Genom08/07/2022464,926
Furlow Brenda S.SVP - General Counsel08/07/2022371,098
Kummeth Charles R.Chief Executive Officer08/07/20224,425,984
Hippel JamesChief Financial Officer08/07/2022742,196
Kummeth Charles R.CHIEF EXECUTIVE OFFICER07/28/202210,549,718
Kummeth Charles R.CHIEF EXECUTIVE OFFICER07/28/20224,919,587
Kummeth Charles R.CHIEF EXECUTIVE OFFICER07/06/202211,222,599
Kummeth Charles R.CHIEF EXECUTIVE OFFICER07/06/20225,424,500
HIGGINS JOHN LDirector06/08/202240,140
HIGGINS JOHN LDirector06/07/202266,900
HIGGINS JOHN LDirector06/07/2022364,310
HIGGINS JOHN LDirector06/08/2022219,654
Kummeth Charles R.CHIEF EXECUTIVE OFFICER06/07/2022553,733
Kummeth Charles R.CHIEF EXECUTIVE OFFICER06/07/20221,862,960
BAUMGARTNER ROBERT VDirector05/10/2022105,765
Kelderman KimPres. Diagnostics & Genom02/08/2022299,901
Kummeth Charles R.Chief Executive Officer01/28/2022199,896
Kelderman KimPres. Diagnostics & Genom11/19/202175,390
Kelderman KimPres. Diagnostics & Genom11/19/2021252,689
Eansor Norman DavidPresident-Protein Sciences11/16/202199,915
Eansor Norman DavidPresident-Protein Sciences11/12/20213,396,233
Eansor Norman DavidPresident-Protein Sciences11/12/202113,688,196
Hippel JamesChief Financial Officer11/02/202125,010
Hippel JamesChief Financial Officer11/01/20211,103,191
Hippel JamesChief Financial Officer11/02/2021105,020
Hippel JamesChief Financial Officer11/01/20214,644,968
Hippel JamesChief Financial Officer10/29/202182,783
Hippel JamesChief Financial Officer10/28/202152,518
Hippel JamesChief Financial Officer10/29/2021347,704
Kelderman KimPres. Diagnostics & Genom09/22/2021434,871
STEER RANDOLPH CDirector09/07/2021716,680
STEER RANDOLPH CDirector09/07/20214,079,824
Kummeth Charles R.Chief Executive Officer09/02/202121,455,314
Kummeth Charles R.Chief Executive Officer09/02/20217,973,147
Hippel JamesChief Financial Officer09/02/20211,065,900
Hippel JamesChief Financial Officer09/02/20215,072,164
Furlow Brenda S.SVP - General Counsel09/02/2021859,219
Furlow Brenda S.SVP - General Counsel09/02/20213,503,767
Eansor Norman DavidPresident-Protein Sciences08/31/2021773,728
Furlow Brenda S.SVP - General Counsel08/31/2021625,250
Furlow Brenda S.SVP - General Counsel08/31/20212,528,312
Nusse RoelandDirector08/23/2021281,400
Nusse RoelandDirector08/23/20211,926,064
BAUMGARTNER ROBERT VDirector08/23/2021349,560
BAUMGARTNER ROBERT VDirector08/23/20211,942,184
Furlow Brenda S.SVP - General Counsel08/19/2021477,030
Furlow Brenda S.SVP - General Counsel08/19/20211,676,850
Kummeth Charles R.Chief Executive Officer08/11/202199,919
Kummeth Charles R.Chief Executive Officer08/06/20216,010,705
Hippel JamesChief Financial Officer08/08/2021802,230
Hippel JamesChief Financial Officer08/09/20211,065,900
Hippel JamesChief Financial Officer08/09/20214,788,994
Kelderman KimPres. Diagnostics & Genom08/08/2021418,702
Furlow Brenda S.SVP - General Counsel08/08/2021326,192
Eansor Norman DavidPresident-Protein Sciences08/08/2021481,338
Hippel JamesChief Financial Officer07/12/20211,065,900
Hippel JamesChief Financial Officer07/12/20214,566,663
Kelderman KimPres. Diagnostics & Genom05/01/2021365,931
Kummeth Charles R.Chief Executive Officer02/16/20217,162,908
Kummeth Charles R.Chief Executive Officer02/16/20212,830,500
Hippel JamesChief Financial Officer02/12/20211,065,900
Hippel JamesChief Financial Officer02/12/20214,003,909
Furlow Brenda S.SVP - General Counsel02/12/20211,065,900
Furlow Brenda S.SVP - General Counsel02/12/20213,986,348
Nusse RoelandDirector02/08/2021404,850
Nusse RoelandDirector02/08/20212,310,480
Kelderman KimPres. Diagnostics & Genom02/05/2021319,694
Eansor Norman DavidPresident-Protein Sciences02/05/20213,510,328
Eansor Norman DavidPresident-Protein Sciences02/05/202112,537,024
Kummeth Charles R.Chief Executive Officer01/15/20216,880,000
Hippel JamesChief Financial Officer01/11/20211,065,900
Hippel JamesChief Financial Officer01/11/20213,336,323
Kummeth Charles R.Chief Executive Officer12/07/20201,540,000
Furlow Brenda S.SVP - General Counsel11/30/20201,257,229
Furlow Brenda S.SVP - General Counsel11/30/20203,278,128
BAUMGARTNER ROBERT VDirector11/18/2020334,500
BAUMGARTNER ROBERT VDirector11/18/20201,516,675
Seth AlpnaDirector11/09/2020732,118
Seth AlpnaDirector11/09/20201,540,167
Hippel JamesChief Financial Officer11/11/2020787,807
Hippel JamesChief Financial Officer11/09/2020383,724
Hippel JamesChief Financial Officer11/09/20201,115,252
Hippel JamesChief Financial Officer11/11/20202,269,426
Kummeth Charles R.Chief Executive Officer11/06/20204,650,476
Kummeth Charles R.Chief Executive Officer11/06/20202,169,791
STEER RANDOLPH CDirector11/06/2020686,250
STEER RANDOLPH CDirector11/06/20203,019,948
HIGGINS JOHN LDirector11/06/2020351,750
HIGGINS JOHN LDirector11/06/20201,501,746
Hippel JamesChief Financial Officer11/05/2020955,688
Hippel JamesChief Financial Officer11/04/2020770,279
Hippel JamesChief Financial Officer11/05/20202,520,454
Hippel JamesChief Financial Officer11/04/20201,945,426
Furlow Brenda S.SVP - General Counsel08/09/2020225,630
Eansor Norman DavidPresident-Protein Sciences08/09/2020227,491
Hippel JamesChief Financial Officer08/09/2020580,420
Kummeth Charles R.Chief Executive Officer08/09/20203,265,393
Furlow Brenda S.SVP - General Counsel07/09/2020984,981
Furlow Brenda S.SVP - General Counsel07/09/20202,503,654
Hippel JamesChief Financial Officer07/07/2020279,579
Hippel JamesChief Financial Officer07/06/20202,332,752
Hippel JamesChief Financial Officer07/07/2020699,482
Hippel JamesChief Financial Officer07/06/20205,840,148
WIENS HAROLD JDirector05/29/2020403,242
WIENS HAROLD JDirector05/29/20201,036,100
Furlow Brenda S.SVP - General Counsel05/28/2020801,358
Furlow Brenda S.SVP - General Counsel05/28/20201,559,534
Eansor Norman DavidPresident-Protein Sciences05/29/2020858,047
Eansor Norman DavidPresident-Protein Sciences05/28/2020374,074
Eansor Norman DavidPresident-Protein Sciences05/28/2020897,135
Eansor Norman DavidPresident-Protein Sciences05/29/20202,072,140
Kummeth Charles R.Chief Executive Officer05/26/20203,467,995
Kummeth Charles R.Chief Executive Officer05/26/20201,824,964
Eansor Norman DavidPresident-Protein Sciences05/22/20201,310,937
Eansor Norman DavidPresident-Protein Sciences05/21/20201,041,341
Eansor Norman DavidPresident-Protein Sciences05/22/20203,375,926
Eansor Norman DavidPresident-Protein Sciences05/21/20202,952,316
BAUMGARTNER ROBERT VDirector05/21/2020351,750
BAUMGARTNER ROBERT VDirector05/21/20201,332,118
WIENS HAROLD JDirector05/06/2020372,068
WIENS HAROLD JDirector05/06/20201,065,000
Kelderman KimPres. Diagnostics & Genom05/01/2020186,810
WIENS HAROLD JDirector04/30/2020367,120
WIENS HAROLD JDirector04/30/2020900,000
Eansor Norman DavidPresident-Protein Sciences03/04/2020275,569
HIGGINS JOHN LDirector02/12/2020307,300
HIGGINS JOHN LDirector02/12/20201,026,135
Kummeth Charles R.Chief Executive Officer01/06/2020693,219
Kummeth Charles R.Chief Executive Officer01/06/20202,232,769
Kummeth Charles R.Chief Executive Officer01/02/20201,338,609
Kummeth Charles R.Chief Executive Officer01/03/2020539,613
Kummeth Charles R.Chief Executive Officer01/03/20201,740,240
Kummeth Charles R.Chief Executive Officer01/02/20204,337,541
Kummeth Charles R.Chief Executive Officer12/24/201931,774
Kummeth Charles R.Chief Executive Officer12/23/201944,456
Kummeth Charles R.Chief Executive Officer12/24/2019104,648
Kummeth Charles R.Chief Executive Officer12/23/2019146,351
Kummeth Charles R.Chief Executive Officer12/20/2019389,042
Kummeth Charles R.Chief Executive Officer12/20/20191,280,632
Kummeth Charles R.Chief Executive Officer12/20/2019389,042
Kummeth Charles R.Chief Executive Officer12/20/20191,280,632
Furlow Brenda S.SVP - General Counsel12/12/2019754,800
Furlow Brenda S.SVP - General Counsel12/12/20191,724,773
Kummeth Charles R.Chief Executive Officer12/10/201947,424
Kummeth Charles R.Chief Executive Officer12/10/2019156,073
WIENS HAROLD JDirector12/04/2019175,660
WIENS HAROLD JDirector12/04/2019435,693
Kummeth Charles R.Chief Executive Officer11/27/2019794,139
Kummeth Charles R.Chief Executive Officer11/29/201922,262
Kummeth Charles R.Chief Executive Officer11/27/20192,614,820
Nusse RoelandDirector11/25/2019911,900
Nusse RoelandDirector11/25/20191,830,731
Hippel JamesChief Financial Officer11/22/20192,231,472
Hippel JamesChief Financial Officer11/21/20191,070,778
Hippel JamesChief Financial Officer11/22/20195,098,899
Hippel JamesChief Financial Officer11/21/20192,444,132
Kummeth Charles R.Chief Executive Officer09/09/201918,500
Kummeth Charles R.Chief Executive Officer09/09/201918,500
Eansor Norman DavidSVP - Novus Biologicals08/19/2019177,813
Hippel JamesChief Financial Officer08/19/2019478,910
Furlow Brenda S.SVP - General Counsel08/19/2019147,190
Kummeth Charles R.Chief Executive Officer08/13/2019499,879
BAUMGARTNER ROBERT VDirector08/07/201995,530
Kummeth Charles R.Chief Executive Officer07/10/20191,144,729
Kummeth Charles R.Chief Executive Officer07/10/20193,616,427
Kummeth Charles R.Chief Executive Officer07/09/20191,014,396
Kummeth Charles R.Chief Executive Officer07/08/20191,213,875
Kummeth Charles R.Chief Executive Officer07/09/20193,194,340
Kummeth Charles R.Chief Executive Officer07/08/20193,828,188
Eansor Norman DavidSVP - Novus Biologicals06/12/2019670,155
HIGGINS JOHN LDirector06/04/2019315,150
HIGGINS JOHN LDirector06/04/20191,018,345
Furlow Brenda S.SVP - General Counsel05/24/20191,080,000
Kelderman KimPresident, Diagnostics & Genom05/01/2019170,598
Kelderman KimPresident, Diagnostics & Genom05/01/2019336,951
Hippel JamesChief Financial Officer05/01/20193,018,750
Hippel JamesChief Financial Officer05/01/20197,107,695
Kummeth Charles R.Chief Executive Officer08/18/2018241,509
BAUMGARTNER ROBERT VDirector08/24/2018307,300
BAUMGARTNER ROBERT VDirector08/24/2018942,335
HIGGINS JOHN LDirector08/23/2018610,800
HIGGINS JOHN LDirector08/23/20181,879,170
Dinarello Charles ADirector08/08/2018315,150
Dinarello Charles ADirector08/08/2018884,675
Kummeth Charles R.Chief Executive Officer08/07/20181,450,667
Eansor Norman DavidSVP - Novus Biologicals08/07/201862,689
Furlow Brenda S.SVP - General Counsel08/07/201878,901
Hippel JamesChief Financial Officer08/07/2018197,073
Kummeth Charles R.Chief Executive Officer06/07/20181,280,000
Eansor Norman DavidSVP - Novus Biologicals05/04/2018164,931
Dinarello Charles ADirector02/13/2018327,350
Dinarello Charles ADirector02/13/2018680,303
BAUMGARTNER ROBERT VDirector11/01/2017315,150
BAUMGARTNER ROBERT VDirector11/01/2017650,905
LUCAS ROGER CDirector10/10/201712,196
LUCAS ROGER CDirector09/08/201712,094
HOLBROOK KAREN ADirector09/06/2017128,909
LUCAS ROGER CDirector08/10/201711,430
LUCAS ROGER CDirector07/10/201711,686
Gould Kevin SSVP Clinical Controls07/09/201736,716
Eansor Norman DavidSVP - Novus Biologicals07/01/201762,745
Furlow Brenda S.07/01/201732,665
LUCAS ROGER CDirector06/09/201711,362
LUCAS ROGER CDirector05/22/2017116,505
Dinarello Charles ADirector05/26/2017332,950
Dinarello Charles ADirector05/31/2017556,860
HOLBROOK KAREN ADirector05/25/2017332,950
HOLBROOK KAREN ADirector05/25/2017555,775
LUCAS ROGER CDirector05/10/201711,059
LUCAS ROGER CDirector04/10/201710,115
Hippel JamesChief Financial Officer03/31/201781,320
LUCAS ROGER CDirector03/10/201710,777
LUCAS ROGER CDirector02/10/201710,260
LUCAS ROGER CDirector01/10/201710,357
LUCAS ROGER CDirector12/09/201610,893
HOLBROOK KAREN ADirector11/29/2016106,733
LUCAS ROGER CDirector11/16/201610,575
LUCAS ROGER CDirector10/19/201610,471
LUCAS ROGER CDirector09/21/201610,891
Gould Kevin SSVP Clinical Controls09/08/201657,904
HIGGINS JOHN LDirector09/08/2016186,716
BAUMGARTNER ROBERT VDirector09/01/2016253,964
BAUMGARTNER ROBERT VDirector09/02/2016171,073
BAUMGARTNER ROBERT VDirector09/01/2016413,052
BAUMGARTNER ROBERT VDirector09/02/2016279,986
BAUMGARTNER ROBERT VDirector08/24/2016235,262
BAUMGARTNER ROBERT VDirector08/24/2016378,377
LUCAS ROGER CDirector08/17/201611,370
LUCAS ROGER CDirector07/20/201611,103
Gould Kevin SSVP Clinical Controls07/09/201635,588
Furlow Brenda S.SVP - General Counsel07/01/201631,090
Eansor Norman DavidSVP - Novus Biologicals07/01/201659,824
LUCAS ROGER CDirector06/15/201611,215
LUCAS ROGER CDirector05/18/201610,253
Dinarello Charles ADirector05/09/2016509,550
Dinarello Charles ADirector05/05/2016280,850
LUCAS ROGER CDirector05/06/201650,120
LUCAS ROGER CDirector04/20/20169,240
Hippel James03/31/201652,553
LUCAS ROGER CDirector03/16/20169,290
LUCAS ROGER CDirector02/05/2016351,750
LUCAS ROGER CDirector02/05/2016418,400
LUCAS ROGER CDirector08/17/2015334,500
LUCAS ROGER CDirector08/17/2015530,110
LUCAS ROGER CDirector08/13/2015307,300
LUCAS ROGER CDirector08/13/2015530,035
Furlow Brenda S.SVP - General Counsel08/07/2015540,372
Eansor Norman DavidSVP Biotech07/02/201551,263
STEER RANDOLPH CDirector06/08/201599,386
VERONNEAU MARCELSVP - Clinical Controls06/08/201530,514
VERONNEAU MARCELSVP - Clinical Controls06/08/201530,573
Hippel JamesChief Financial Officer03/31/201556,764
OCONNELL HOWARD VDirector02/19/2015280,850
OCONNELL HOWARD VDirector02/19/2015478,882
Dinarello Charles ADirector02/05/201582,365
HOLBROOK KAREN ADirector12/10/201492,400
Dinarello Charles ADirector12/08/2014271,320
REAGAN KEVIN JSenior VP - Biotech12/09/2014183,857
REAGAN KEVIN JSenior VP - Biotech12/05/201470,960
REAGAN KEVIN JSenior VP - Biotech12/09/2014231,432
REAGAN KEVIN JSenior VP - Biotech12/05/201489,412
Dinarello Charles ADirector09/09/2014274,550
HOLBROOK KAREN ADirector08/14/2014285,300
HOLBROOK KAREN ADirector08/14/2014477,700
VERONNEAU MARCELVP Clinical Controls06/02/201428,910
VERONNEAU MARCELVP Clinical Controls06/02/201428,983
OCONNELL HOWARD VDirector05/06/201451,071
OCONNELL HOWARD VDirector05/07/2014222,329
OCONNELL HOWARD VDirector05/06/201484,994
OCONNELL HOWARD VDirector05/07/2014370,006
HOLBROOK KAREN ADirector03/04/2014285,300
HOLBROOK KAREN ADirector03/04/2014449,150
STEER RANDOLPH CDirector02/27/2014307,300
STEER RANDOLPH CDirector02/27/2014443,900
LUCAS ROGER CDirector02/19/2014975,450
LUCAS ROGER CDirector02/19/20141,350,507
STEER RANDOLPH CDirector11/13/2013975,450
STEER RANDOLPH CDirector11/13/20131,293,000
BAUMGARTNER ROBERT VDirector11/08/2013554,250
BAUMGARTNER ROBERT VDirector11/08/2013870,000
LUCAS ROGER CDirector11/04/2013554,250
LUCAS ROGER CDirector11/04/2013876,400
VERONNEAU MARCELVP Clinical Controls07/01/201328,015
VERONNEAU MARCELVP Clinical Controls07/01/201328,027
OCONNELL HOWARD VDirector05/06/2013153,465
MELSEN GREGORY JCEO12/18/201250,023
OCONNELL HOWARD VDirector10/27/20121,433,000
OCONNELL HOWARD VDirector10/26/2012185,500
OCONNELL HOWARD VDirector10/26/2012574,480
VERONNEAU MARCELVP Hematology Operations08/14/201224,510
VERONNEAU MARCELVP Hematology Operations08/14/201232,096
MELSEN GREGORY JVP Finance and CFO07/31/201221,982
OLAND THOMAS ECEO, President11/30/2011134,980
OCONNELL HOWARD VDirector12/05/201123,282
OLAND THOMAS ECEO, President11/30/2011134,980
OCONNELL HOWARD VDirector11/29/20111,950,600
BAUMGARTNER ROBERT VDirector11/25/201162,610
VERONNEAU MARCELVP Hematology Operations05/26/201120,437
VERONNEAU MARCELVP Hematology Operations05/26/201141,004
BAUMGARTNER ROBERT VDirector05/09/2011207,872
BAUMGARTNER ROBERT VDirector05/06/201162,017
BAUMGARTNER ROBERT VDirector05/06/2011148,312
BAUMGARTNER ROBERT VDirector05/09/2011445,880
BAUMGARTNER ROBERT VDirector05/04/201180,112
BAUMGARTNER ROBERT VDirector05/04/2011191,974
OCONNELL HOWARD VDirector05/04/2011128,838
OCONNELL HOWARD VDirector05/04/2011317,750
OCONNELL HOWARD VDirector05/04/20111,187,807
OCONNELL HOWARD VDirector12/08/201087,300
OCONNELL HOWARD VDirector12/08/2010183,900
OLAND THOMAS ECEO, President11/09/2010120,440
OCONNELL HOWARD VDirector11/03/2010526,565
OCONNELL HOWARD VDirector11/03/2010610,100
VERONNEAU MARCELVP Hematology Operations11/02/2010277,121
VERONNEAU MARCELVP Hematology Operations11/03/2010277,990
VERONNEAU MARCELVP Hematology Operations11/02/2010277,175
VERONNEAU MARCELVP Hematology Operations11/03/2010458,772
LUCAS ROGER CDirector08/20/2010526,565
LUCAS ROGER CDirector08/20/2010600,150
VERONNEAU MARCELVP Hematology Operations08/04/201022,671
VERONNEAU MARCELVP Hematology Operations08/04/201022,679
Load More Insider Transactions
FUNDS WITH A POSITION IN BIO-TECHNE CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.17,745,9770.03%-2.14%Other
BAMCO INC /NY/4,998,2100.94%-6.61%Growth At A Reasonable Price
SELECT EQUITY GROUP, L.P.3,010,7430.75%-33.96%Growth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC3,838,2100.02%3.13%Other
ROYCE & ASSOCIATES LP796,5640.5%16.55%Value
ADAGE CAPITAL PARTNERS GP, L.L.C.353,6000.06%ExitedOther
AQR CAPITAL MANAGEMENT LLC51,0890.00608%-15.36%Other
POLEN CAPITAL MANAGEMENT LLC37,0240.00602%65.41%Growth At A Reasonable Price, Growth
ASHFORD CAPITAL MANAGEMENT INC23,2300.22%27.92%Growth
PLATINUM INVESTMENT MANAGEMENT LTD22,8240.06%NewGrowth At A Reasonable Price, Value
TUDOR INVESTMENT CORP ET AL18,1830.00814%NewEvent Driven, Other
WCM INVESTMENT MANAGEMENT, LLC13,2200.00221%1.47%Growth At A Reasonable Price
SANDS CAPITAL MANAGEMENT, LLC12,7320.00251%1.42%Growth At A Reasonable Price, Growth
BRIDGEWATER ASSOCIATES, LP4,0820.00145%-44.1%Other
SUVRETTA CAPITAL MANAGEMENT, LLC2,6000.00907%ExitedGrowth At A Reasonable Price
CHANGE IN SHARES OUTSTANDING FOR BIO-TECHNE CORP
STOCK BUYBACKS FOR BIO-TECHNE CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.27%
1Q
03/31/2024
09/30/2023
-0.89%
2Q
03/31/2024
06/30/2023
-1.00%
3Q
03/31/2024
03/31/2023
-0.69%
4Q
03/31/2024
12/31/2022
-0.78%
5Q
03/31/2024
09/30/2022
-1.03%
6Q
03/31/2024
06/30/2022
-1.89%
7Q
03/31/2024
03/31/2022
-2.06%
8Q
03/31/2024
12/31/2021
-2.63%
9Q
03/31/2024
09/30/2021
-2.51%
10Q
03/31/2024
06/30/2021
-2.18%
11Q
03/31/2024
03/31/2021
-1.36%
12Q
03/31/2024
12/31/2020
-0.33%
13Q
03/31/2024
09/30/2020
0.25%
14Q
03/31/2024
06/30/2020
1.47%
15Q
03/31/2024
03/31/2020
1.75%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.27%
1Q
09/30/2023
-0.89%
2Q
06/30/2023
-1.00%
3Q
03/31/2023
-0.69%
4Q
12/31/2022
-0.78%
5Q
09/30/2022
-1.03%
6Q
06/30/2022
-1.89%
7Q
03/31/2022
-2.06%
8Q
12/31/2021
-2.63%
9Q
09/30/2021
-2.51%
10Q
06/30/2021
-2.18%
11Q
03/31/2021
-1.36%
12Q
12/31/2020
-0.33%
13Q
09/30/2020
0.25%
14Q
06/30/2020
1.47%
15Q
03/31/2020
1.75%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIO-TECHNE CORP
LOADING...